Sectors

Data Insights

CBP-1019 by Coherent Biopharma for Esophageal Cancer: Likelihood of Approval

Data Insights

LY-3461767 by Eli Lilly and Co for Chronic Heart Failure: Likelihood of Approval

Data Insights

ALXN-2030 by Alexion Pharmaceuticals for Antibody-Mediated Rejection (AMR): Likelihood of Approval

Data Insights

ITM-52 by ITM Isotope Technologies Munich for Adenocarcinoma: Likelihood of Approval

Data Insights

KFA-115 by Novartis for Hematological Tumor: Likelihood of Approval

Data Insights

Crizotinib by Pfizer for Breast Cancer: Likelihood of Approval

Data Insights

OC-514 by Korea Pharma for Sarcopenia: Likelihood of Approval

Data Insights

Rapcabtagene autoleucel by Novartis for Lupus Nephritis: Likelihood of Approval

Clinical Trials

News

Deka Biosciences secures $20m to advance product pipeline

News

Bidco to acquire biopharmaceutical services company Ergomed

News

Bristol Myers Squibb receives FDA approval for Reblozyl to treat anaemia

Drug Manufacturers

Comment

Can reforms restore faith in India’s pharma industry after cough syrup scandals?

GlobalData Healthcare

News

ADDF invest in BrainScope for Alzheimer’s prediction biomarker

Comment

European PFAS ban would burden drug companies and packagers

GlobalData Healthcare

Therapy Area

News

Amicus receives FDA approval for Pompe disease therapy

News

Fabre-Kramer gains FDA approval for major depressive disorder therapy

News

Roche gains rights to Ionis’ Alzheimer’s and Huntington’s programmes

Pricing and Market Access

Analyst Comment

Over half of world’s population not covered by essential healthcare services

Analyst Comment

Minimal impact expected for first ten drugs released for Medicare price negotiation

Analyst Comment

House Democrats unveil new legislation that expands the Inflation Reduction Act